Ascletis Pharma Inc.

Investors

Next Day Disclosure Returns - Others
2023-08-15
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
2023-08-02
Voluntary Announcement - Shanghai Public Health Clinical Center Presented Clinical Results of ASC22 (Envafolimab) in Combination with Chidamide for Functional Cure of HIV Infection at the 12th IAS Conference on HIV Science
2023-07-25
Notice of Board Meeting
2023-07-21
Next Day Disclosure Returns - Share Buyback
2023-07-20
Voluntary Announcement - Gannex Announces the Completion of Patient Enrollment for Phase II Clinical Trial of ASC42, an FXR Agonist, for Primary Biliary Cholangitis
2023-07-20
Next Day Disclosure Returns - Share Buyback
2023-07-19
Positive Profit Alert
2023-07-18
Next Day Disclosure Returns - Share Buyback
2023-07-14
Next Day Disclosure Returns - Share Buyback
2023-07-13

3

© 2018 Ascletis Pharma Inc. All Rights Reserved
浙公网安备 33010802003344号浙ICP备11050387号-1